Search research articles
Contact Us
Filters
Showing results (31-40 of 247) with videos related to
Page
of 25
Sort By:
Gastrointestinal Endoscopy
|
July 3, 2003
EMR as salvage treatment for patients with locoregional failure of definitive chemoradiotherapy for esophageal cancer
Santa Hattori, Manabu Muto, Atsushi Ohtsu, et al.
Japanese Journal of Clinical Oncology
|
September 29, 2009
Phase I clinical and pharmacokinetic study of RAD001 (everolimus) administered daily to Japanese patients with advanced solid tumors
Isamu Okamoto, Toshihiko Doi, Atsushi Ohtsu, et al.
The Oncologist
|
April 24, 2020
Phase I Study of the Bifunctional Fusion Protein Bintrafusp Alfa in Asian Patients with Advanced Solid Tumors, Including a Hepatocellular Carcinoma Safety-Assessment Cohort
Toshihiko Doi, Yutaka Fujiwara, Takafumi Koyama, et al.
Cancer Chemotherapy and Pharmacology
|
April 5, 2011
Amrubicin for the treatment of neuroendocrine carcinoma of the gastrointestinal tract: a retrospective analysis of five cases
Masako Asayama, Nozomu Fuse, Takayuki Yoshino, et al.
International Journal of Clinical Oncology
|
April 25, 2009
Sunitinib-resistant gastrointestinal stromal tumors harbor cis-mutations in the activation loop of the KIT gene
Toshirou Nishida, Tsuyoshi Takahashi, Akiko Nishitani, et al.
Investigational New Drugs
|
September 5, 2009
Phase I/II study of sunitinib malate in Japanese patients with gastrointestinal stromal tumor after failure of prior treatment with imatinib mesylate
Kuniaki Shirao, Toshirou Nishida, Toshihiko Doi, et al.
Masui. the Japanese Journal of Anesthesiology
|
July 22, 2006
[Usefulness of intraoperative transesophageal echocardiography in stent graft implantation for thoracic descending aorta]
Toshiko Katayama, Kazuhito Nitta, Shinji Kawahito, et al.
Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association
|
August 12, 2016
Analysis of esophagogastric cancer patients enrolled in the National Cancer Institute Cancer Therapy Evaluation Program sponsored phase 1 trials
Hideaki Bando, Larry Rubinstein, Pamela Harris, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 9, 2017
Safety and Antitumor Activity of the Anti-Programmed Death-1 Antibody Pembrolizumab in Patients With Advanced Esophageal Carcinoma
Toshihiko Doi, Sarina A Piha-Paul, Shadia I Jalal, et al.
International Journal of Clinical Oncology
|
February 7, 2015
Regorafenib for advanced gastrointestinal stromal tumors following imatinib and sunitinib treatment: a subgroup analysis evaluating Japanese patients in the phase III GRID trial
Yoshito Komatsu, Toshihiko Doi, Akira Sawaki, et al.
Page
of 25
Search research articles
Search
Showing results (31-40 of 247) with videos related to
Sort By:
Page
of 25
Gastrointestinal Endoscopy
|
July 3, 2003
EMR as salvage treatment for patients with locoregional failure of definitive chemoradiotherapy for esophageal cancer
Santa Hattori, Manabu Muto, Atsushi Ohtsu, et al.
Japanese Journal of Clinical Oncology
|
September 29, 2009
Phase I clinical and pharmacokinetic study of RAD001 (everolimus) administered daily to Japanese patients with advanced solid tumors
Isamu Okamoto, Toshihiko Doi, Atsushi Ohtsu, et al.
The Oncologist
|
April 24, 2020
Phase I Study of the Bifunctional Fusion Protein Bintrafusp Alfa in Asian Patients with Advanced Solid Tumors, Including a Hepatocellular Carcinoma Safety-Assessment Cohort
Toshihiko Doi, Yutaka Fujiwara, Takafumi Koyama, et al.
Cancer Chemotherapy and Pharmacology
|
April 5, 2011
Amrubicin for the treatment of neuroendocrine carcinoma of the gastrointestinal tract: a retrospective analysis of five cases
Masako Asayama, Nozomu Fuse, Takayuki Yoshino, et al.
International Journal of Clinical Oncology
|
April 25, 2009
Sunitinib-resistant gastrointestinal stromal tumors harbor cis-mutations in the activation loop of the KIT gene
Toshirou Nishida, Tsuyoshi Takahashi, Akiko Nishitani, et al.
Investigational New Drugs
|
September 5, 2009
Phase I/II study of sunitinib malate in Japanese patients with gastrointestinal stromal tumor after failure of prior treatment with imatinib mesylate
Kuniaki Shirao, Toshirou Nishida, Toshihiko Doi, et al.
Masui. the Japanese Journal of Anesthesiology
|
July 22, 2006
[Usefulness of intraoperative transesophageal echocardiography in stent graft implantation for thoracic descending aorta]
Toshiko Katayama, Kazuhito Nitta, Shinji Kawahito, et al.
Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association
|
August 12, 2016
Analysis of esophagogastric cancer patients enrolled in the National Cancer Institute Cancer Therapy Evaluation Program sponsored phase 1 trials
Hideaki Bando, Larry Rubinstein, Pamela Harris, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 9, 2017
Safety and Antitumor Activity of the Anti-Programmed Death-1 Antibody Pembrolizumab in Patients With Advanced Esophageal Carcinoma
Toshihiko Doi, Sarina A Piha-Paul, Shadia I Jalal, et al.
International Journal of Clinical Oncology
|
February 7, 2015
Regorafenib for advanced gastrointestinal stromal tumors following imatinib and sunitinib treatment: a subgroup analysis evaluating Japanese patients in the phase III GRID trial
Yoshito Komatsu, Toshihiko Doi, Akira Sawaki, et al.
Page
of 25